Literature DB >> 4141657

Antibodies to collagen in patients with emphysema.

D Michaeli, H H Fudenberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4141657     DOI: 10.1016/0090-1229(74)90004-x

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


× No keyword cloud information.
  8 in total

1.  Binding of native and denatured collagen to immunoglobulins and cold insoluble globulin in serum of patients undergoing orthopedic surgery.

Authors:  B Adelmann; B Schöning
Journal:  Klin Wochenschr       Date:  1980-06-16

2.  Antibodies to denatured bovine collagens in sera of patients with liver disease.

Authors:  T Suou; C Hirayama
Journal:  Clin Exp Immunol       Date:  1980-01       Impact factor: 4.330

3.  Immunologic characterization of the membrane-bound collagen in normal human fibroblasts: identification of a distinct membrane collagen.

Authors:  J R Lichtenstein; E A Bauer; R Hoyt; H J Wedner
Journal:  J Exp Med       Date:  1976-07-01       Impact factor: 14.307

4.  Autoantibodies in childhood scleroderma.

Authors:  R M Bernstein; R S Pereira; A J Holden; C M Black; A Howard; B M Ansell
Journal:  Ann Rheum Dis       Date:  1985-08       Impact factor: 19.103

5.  Pathogenic mechanisms in pulmonary fibrosis: collagen-induced migration inhibition factor production and cytotoxicity mediated by lymphocytes.

Authors:  T C Kravis; A Ahmed; T E Brown; J D Fulmer; R G Crystal
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

6.  Incidence of serum antibodies to native type I and type II collagens in patients with inflammatory arthritis.

Authors:  R B Clague; M J Shaw; P J Holt
Journal:  Ann Rheum Dis       Date:  1980-06       Impact factor: 19.103

Review 7.  The role of collagenase in emphysema.

Authors:  R Foronjy; J D'Armiento
Journal:  Respir Res       Date:  2001-09-19

8.  Cross-reactivity of cell-mediated immunity between interstitial (type I) and basement membrane (type IV) collagens.

Authors:  A M Mackel; F DeLustro; E C LeRoy
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.